AKT1 and liver cancer: Using the AKT activator SC79 [35], we confirmed that the AKT/mTOR signaling pathway can counteract the inhibitory effects of Let‐7b‐5p on HCC cell proliferation while promoting apoptosis and inhibiting the migration of liver cancer cells (Figures 5 and 6).